Article Details

Edesa Biotech Receives C$14 million for COVID-19 Study

Retrieved on: 2021-02-02 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Edesa Biotech Receives C$14 million for COVID-19 Study. View article details on hiswai:

Excerpt

EB05 is an experimental monoclonal antibody that Edesa believes could ... The company is developing late-stage monoclonal antibodies that block ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up